Latest News about AXSM
Recent news which mentions AXSM
From Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
From Benzinga
3 Healthcare Stocks That Might Skyrocket When COVID Is Over
September 07, 2021
From Motley Fool
3 Biotech Stocks Wall Street Expects to Double Soon
September 07, 2021
From Motley Fool
Buy, Sell, or Hold Axsome Therapeutics Stock After Its FDA Approval Delay?
September 05, 2021
Tickers
AXSM
From Motley Fool
3 Biotech Stocks That Are Too Cheap to Ignore
September 02, 2021
From Motley Fool
Here's Why Axsome Therapeutics Stock Is Surging Today
September 01, 2021
Tickers
AXSM
From Motley Fool
10 Biggest Price Target Changes For Monday
August 30, 2021
From Benzinga
Which Biotech Stock Will Shock the Market in 2022?
August 27, 2021
From Motley Fool
12 Health Care Stocks Moving In Tuesday's After-Market Session
August 24, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 23, 2021
From Benzinga
From InvestorPlace
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
August 22, 2021
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
Could Biogen Acquire Axsome Therapeutics?
August 20, 2021
From Motley Fool
From Benzinga
From Benzinga
From Benzinga
2 Beaten-Down Biotech Stocks: Are They Bargains Now?
August 17, 2021
From Motley Fool
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
August 15, 2021
From Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
From Benzinga
Is Axsome Therapeutics Stock Ready to Rebound?
August 12, 2021
From Motley Fool
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 10, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
|
|
|
|
|
|